New Cholesterol Drugs Vastly Overpriced, Study Contends

TUESDAY, Aug. 22, 2017 — Are new medicines for people with out-of-control cholesterol wildly overpriced? It’s a question that’s sparking debate among consumers and providers of care.
Now, researchers at the University of California, San Francisco…
Source: Topamax